Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Apr 04, 2024

SELL
$62.39 - $113.8 $686 - $1,251
-11 Reduced 45.83%
13 $1.48 Million
Q3 2022

Apr 04, 2024

BUY
$58.92 - $84.67 $1,178 - $1,693
20 Added 500.0%
24 $1.49 Million
Q2 2022

Apr 04, 2024

BUY
$79.4 - $116.36 $317 - $465
4 New
4 $320,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.